The GLP-1 Blind Spot: Fast Weight Loss and the Strength You Don't Want to Lose

"The number on the scale is only part of the story."

GLP-1 medications have changed the conversation around weight management. They work. For many people, medications such as semaglutide can support meaningful weight loss and improve important health markers.

But there is another part of the conversation that deserves attention: GLP-1 muscle loss...

What GLP-1 medications do

GLP-1 medications help regulate appetite, digestion, and blood sugar. They can make it easier to reduce food intake and maintain a calorie deficit over time.

That can support weight loss. It can also improve health risks connected to excess body weight.

The goal should not be to criticize medication-based care. GLP-1 medications are legitimate tools when prescribed and monitored by an appropriate medical professional.

The important question is this: What type of weight are you losing?

The muscle-loss blind spot

Weight loss can include fat, water, and lean tissue. Lean tissue includes muscle, but it is not identical to muscle.

Research shows that people taking semaglutide and other GLP-1 medications can lose some lean mass during weight loss. The amount varies by the individual, the rate of weight loss, food intake, activity level, age, and starting strength.

This does not mean that Ozempic automatically causes sarcopenia. It does mean that muscle health should be part of the plan.

A lower number on the scale does not tell you whether you are maintaining your strength, balance, or ability to perform daily activities.

Why muscle matters more than the scale

Muscle supports more than appearance or athletic performance. It helps you:

• Climb stairs and rise from a chair

• Protect and stabilize your joints

• Maintain balance and reduce fall risk

• Support your metabolism

• Recover from illness, injury, or surgery

• Stay independent as you age

Sarcopenia refers to a clinically meaningful decline in muscle strength, function, and sometimes muscle quantity. It is not diagnosed by looking at body weight alone.

So what should you monitor? Strength. Function. Balance. Walking ability. Your capacity to perform the activities that matter to you.

Where physical therapy fits

Physical therapy is not a replacement for GLP-1 medication. It is a valuable partner alongside it.

A physical therapist can help establish a baseline and identify areas that need attention. This may include leg strength, grip strength, balance, mobility, joint pain, and everyday movement.

Your plan should match your current ability. Someone who is already active may need a different approach than someone experiencing fatigue, joint pain, deconditioning, or difficulty getting up from a chair.

At Dynamic Edge Physiotherapy, we build personalized exercise plans around your goals, medical history, and lifestyle. Our custom therapeutic exercise plans can support strength and function during major health changes.

For some patients, Blood Flow Restriction Training may also be considered. This technique uses lighter resistance while creating a targeted training stimulus. It must be selected and supervised by a qualified professional.

The right approach includes more than walking. Muscle-strengthening exercise, appropriate nutrition, recovery, and regular progress checks all matter.

More to come

The conversation around Ozempic and muscle loss is becoming more important as more people use GLP-1 medications.

Our upcoming public lecture will explore this topic in greater detail, including what to watch, how strength is assessed, and how physical therapy can support long-term function. We will share more soon.

If you are taking a GLP-1 medication and want to discuss strength, mobility, or exercise planning, call Dynamic Edge Physiotherapy at (203) 978-3343 or email info@dynamicedgept.com. We serve patients throughout Fairfield County, including Wilton and Monroe, Connecticut.

Sources: New England Journal of Medicine semaglutide trial and a 2026 systematic review of GLP-1 medications and muscle health.